Talk:Lanreotide

From Wikipedia, the free encyclopedia

Lanreotide is part of WikiProject Pharmacology, a project to improve all Pharmacology-related articles. If you would like to help improve this and other pharmacology articles, please join the project. All interested editors are welcome.
Start This article has been rated as Start-Class on the quality scale.

[edit] Improvement

To do:

  • Find more info for Drugbox
  • Avoid repetition of name—lanreotide, lanreotide, lanreotide...
  • Find more refs and better refs
  • Add more on the use of radiolabeled lanreotide?
  • Add more on efficacy and comparison to octreotide.
  • Interesting refs:
    • Freda P, Katznelson L, van der Lely A, Reyes C, Zhao S, Rabinowitz D (2005). "Long-acting somatostatin analog therapy of acromegaly: a meta-analysis". J Clin Endocrinol Metab 90 (8): 4465–73. PMID 15886238. 
    • Kaltsas G, Papadogias D, Makras P, Grossman A (2005). "Treatment of advanced neuroendocrine tumours with radiolabelled somatostatin analogues". Endocr Relat Cancer 12 (4): 683–99. PMID 16322317.  Free full text

Fvasconcellos 02:55, 3 March 2007 (UTC)

[edit] Oral Lanreotide

Do you think that one day there will be an oral form of Lanreotide or octreotide? —Preceding unsigned comment added by Interestedperson (talk • contribs)

Well, there has been some development of orally active somatostatin analogues,[1][2][3] although not recently AFAIK. Very high oral doses of octreotide do produce some effect, comparable to a low parenteral dose (there's a reference for that somewhere). Perhaps somatostatin analogues with appropriate structural modifications will reach the market someday... Fvasconcellos (t·c) 19:19, 17 July 2007 (UTC)